医学
大流行
分离(微生物学)
2019年冠状病毒病(COVID-19)
病毒学
冠状病毒
限制
2019-20冠状病毒爆发
接种疫苗
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
天花
疾病
爆发
传染病(医学专业)
生物信息学
生物
工程类
病理
机械工程
作者
Amr Hany Saleh,Shahraz Qamar,Aysun Tekin,Romil Singh,Rahul Kashyap
出处
期刊:Cureus
[Cureus, Inc.]
日期:2021-07-26
被引量:16
摘要
The emergence of the coronavirus disease 2019 (COVID-19) pandemic has made us appreciate how important it is to quickly develop treatments and save lives. The race to develop a vaccine for this novel coronavirus began as soon as the pandemic emerged. Time was the only limiting factor. From the first vaccine developed in 1796 against smallpox to the latest COVID-19 vaccine, there have been several vaccines that have reduced the burden of disease, with the associated mortality and morbidity. Over the years we have seen many new advancements in organism isolation, cell culture, whole-genome sequencing, and recombinant nuclear techniques. These techniques have greatly facilitated the development of vaccines. Each vaccine has its own development story and there is much wisdom to be gained from learning about breakthroughs in vaccine development.
科研通智能强力驱动
Strongly Powered by AbleSci AI